Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: Long term follow-up of two randomized, placebo-controlled trials

Cancer

Volumn 88, Issue 5, 2000, Pages 1082-1090

  Lipton, Allan ^a   Theriault, Richard L ^b   Hortobagyi, Gabriel N ^b   Simeone, Joseph ^c   Knight, Robert D ^d   Mellars, Kathleen ^d   Reitsma, Dirk J ^d   Heffernan, Maika ^d   Seaman, John J ^d  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Bisphosphonates; Bone; Metastases; Pamidronate

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; ANTINEOPLASTIC AGENT; BIOCHEMICAL MARKER; CALCIUM; CREATININE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; HYDROXYPROLINE; MEGESTROL ACETATE; PAMIDRONIC ACID; TAMOXIFEN;

ADULT; AGED; ALLERGIC REACTION; ARTICLE; BONE DISEASE; BONE METASTASIS; BONE PAIN; BREAST CARCINOMA; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FATIGUE; FEMALE; FEVER; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MUSCLE WEAKNESS; OSTEOLYSIS; PALLIATIVE THERAPY; PATHOLOGIC FRACTURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; BREAST NEOPLASMS; DIPHOSPHONATES; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; OSTEOLYSIS; PAIN; PALLIATIVE CARE; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 0034162528     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z     Document Type: Article

References (26)

1. Abram HL, Spiro R, Goldstein N. Metastases in carcinoma. Analysis of 1000 autopsied cases. Cancer 1950;23:74-85.
2. Malawer MH, Delaney TF. Treatment of metastatic cancer to bone. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles & practice of oncology. 4th edition. Philadelphia: J.B. Lippincott Co., 1993.
3. Mundy GR. Mechanism of osteolytic bone destruction. Bone 1991;12(Suppl 1):51-6.
4. Mundy GR, Ibbotson KI, D'Souza SM, Simpson EL, Jacobs JW, Martin TJ. The hypercalcemia of cancer. N Engl J Med 1984;310:1718-27.
5. Scher HI, Yogoda A. Bone metastases: pathogenesis, treatment, and rationale for use of resorption inhibitors. Am J Med 1987;82(Suppl A):6-28.
6. Dodwell DJ. Malignant bone resorption: cellular and biochemical mechanisms. Ann Oncol 1992;3:257-67.
7. Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S, et al. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. N Engl J Med 1996;334:488-93.
8. Hortobagyi GN, Theriault RL, Porter L, Blayney D, Lipton A, Sinoff C, et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. N Engl J Med 1996;335:1785-91.
9. Nussbaum SR, Younger J, VandePol CJ, Gagel RF, Zubler MA, Chapman R, et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy. Am J Med 1993;95:297-304.
10. Gucalp R, Ritch P, Wiernick PH, Sarma PR, Keller A, Richman SP, et al. Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia. J Clin Oncol 1992;10:134-42.
11. Henderson IC, Allegra JC, Woodcock T, Wolff S, Bryan S, Cartwright K, et al. Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer. J Clin Oncol 1989;7: 560-71.
12. Parvinen L-M, Numminen S. Chemotherapy in advanced breast carcinoma. Comparison between doxorubicin-cyclophosphamide and cyclophosphamide-methotrexate-5-fluorouracil-vincristine-prednisone. Acta Radiol Oncol 1985; 24:391-4.
13. Brunner KW, Sonntag RW, Alberto P, Senn HJ, Martz G, Obrecht P, et al. Combined chemo- and hormonal therapy in advanced breast cancer. Cancer 1977;39:2923-33.
14. Perry MC, Kardinal CG, Korzun AH, Ginsberg SJ, Raich PC, Holland JF, et al. Chemohormonal therapy in advanced carcinoma of the breast: Cancer and Leukemia Group B Protocol 8081. J Clin Oncol 1987;5:1534-45.
15. Hortobagyi GN, Theriault RL, Lipton A, Porter L, Blayney D, Sinoff C, et al. Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. J Clin Oncol 1998;16:2038-44.
16. Beahrs OH, Henson DE, Hutter RVP, Myers MH, editors. Manual for staging of cancer. 3rd edition. Philadelphia: J.B. Lippincott, 1988.
17. Tong D, Gillick L, Hendrickson FR. The palliation of symptomatic osseous metastases: final results of the study by the Radiation Therapy Oncology Group. Cancer 1982;50:893-9.
18. Spitzer WO, Dobson AJ, Hall J, et al. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chron Dis 1981;34:585-97.
19. Hayward JL, Carbone PP, Henson J-C, Kumaoka S, Segaloff A, Rubens RD. Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland. Cancer 1977;39:1289-94.
20. Lipton A. Bisphosphonates and breast carcinoma. Cancer 1997;80:1668-73.
21. Glover D, Lipton A, Keller A, Miller AA, Browning S, Fram RJ, et al. Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer: a dose-seeking study. Cancer 1994;74:2949-56.
22. Coleman RE, Woll PJ, Miles M, Scrivener W, Rubens RD. 3-amino-1,1 hydroxypropylidene bisphosphonate (APD) for the treatment of bone metastases fom breast cancer. Br J Cancer 1988;58:621-5.
23. Aaron AD. Current Concepts Review-Treatment of metastatic adenocarcinoma of the pelvis and extremities. J Bone Joint Surg Am 1997;79-A(6):917-32.
24. Robinson RG, Blake GM, Preston DF, McEwan AJ, Spicer JA, Martin NL, et al. Strontium-89: treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone. Radiographies 1989;9:271-81.
25. Hoskin PJ, Price P, Easton D, Regan J, Austin D, Palmer S, et al. A prospective randomized trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother Oncol 1992;23:74-8.
26. Mithal NP, Needham PR, Hoskin PJ. Retreatment with radiotherapy for painful bone metastases. Int J Radiat Oncol Biol Phys 1994;29:1011-14.